27
May

GlobeImmune’s in-development vaccine for hepatitis B missed the mark in a Phase II trial, marring the value of a program licensed to Gilead Sciences.

…read more

Source: GlobeImmune’s Gilead-partnered hep B vaccine fails in Phase II

    

0 No comments